Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: T4/T3 Therapy in Hypothyroidism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at the University of Pennsylvania is evaluating T4/T3 therapy for hypothyroidism, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)
  • Liothyronine (liothyronine)

Snippet

Sponsor: University of Pennsylvania | Conditions: Hypothyroidism Primary | Phase 2 | Status: NOT_YET_RECRUITING